Visit
VJHemOnc is pleased to bring you a feature exploring the latest thinking on the application of MRD in AML trials…
Zanubrutinib was approved by the Food and Drug Administration (FDA) on the 19th of January 2023, for the treatment of…
VJHemOnc is thrilled to bring you the latest updates from the 64th American Society of Hematology (ASH) Annual Meeting and…
VJHemOnc is pleased to bring you a feature covering the current state of the field in the treatment CP-CML with…
VJHemOnc is excited to bring you the latest research updates in myeloid malignancies from the EHA 2022 Congress, which took…
Learn about the importance of performing genomic testing in CLL and how this impacts diagnosis, prognosis and treatment decisions.
VJHemOnc is excited to bring you the latest research updates in CAR-T therapy from the EBMT-EHA 4th European CAR T-cell…
On October 1, 2021, the US Food and Drug Administration (FDA) approved the use of brexucabtagene autoleucel, an autologous CD19-directed…
The introduction of chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of B-cell acute lymphoblastic leukemia (B-ALL) has significantly…
The 26th Congress of the European Hematology Association (EHA) 2021, which was held virtually from 9-17 of June, 2021, offered…
VJHemOnc is excited to bring you highlights from the 47th Annual Meeting of the European Group for Blood and Marrow…
A session with myelodysplastic syndromes (MDS) expert John Bennett who discusses MDS diagnosis and prognosis.
Bruton’s tyrosine kinase (BTK) plays an essential role in the B-cell antigen receptor signaling pathway and is required for the…
A session with experts Erik Aerts, John Murray, Michelle Kenyon & Rose Ellard who cover key areas discussed during the…
A session with experts Bruce Levine and Christian Chabannon, who discuss the exciting updates in transplantation and cell therapy from…
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest hemonc news and updates
Keep up to date with all the latest news with our monthly newsletter